Nachrichten zur Eli Lilly & Co. Aktie

Eli Lilly, Pfizer Land on China’s First Private Insurance List

Eli Lilly & Co., Pfizer Inc. and Johnson & Johnson secured spots on China’s first innovative drug catalog, opening a…

Eli Lillys Stock Drops as It Slashes the Price of Zepbound: Time to Buy the Dip?

This is no reason to panic.…

Meet the Supercharged Growth Stock That Could Join Apple, Nvidia, Microsoft, and Alphabet in the $2 Trillion Club by 2028

Eli Lillys stock price and market cap are poised to explode with the GLP-1 market.…

Eli Lilly, Alphabet Among Megacap Leaders On This Growth List

Eli Lilly, Alphabet are in the IBD 50 list of growth stocks. Taiwan Semiconductor and AppLovin are near buy points…

With Netflixs 10-for-1 Stock Split Complete, Here Are 3 Growth Stocks to Buy in December That Could Issue Stock Splits in 2026

Surging stock prices and earnings growth potential make Meta Platforms, ASML, and Eli Lilly ripe for stock splits in the…

Small Caps Lead Again, Lilly Tested; 5 Stocks In Buy Areas

Dow Jones futures: Small caps nearly hit new highs as the major indexes paused. Eli Lilly is at a key…

Here are Tuesdays biggest analyst calls: Nvidia, Apple, AMD, Micron, Amazon, Eli Lilly, Cloudflare & more

Here are Tuesdays biggest calls on Wall Street.…

Bank of America hikes Eli Lilly price target on promising drug pipeline

Bank of Americas new price target has shares of Eli Lilly climbing 22% from here.…

LLY Lowers Prices of Zepbound Vials for Cash Buyers on DTC Website

Eli Lilly trims Zepbound vial prices on LillyDirect, offering lower monthly costs for self-paying patients across multiple doses.…

What Eli Lillys move to cut prices on obesity drug Zepbound means for investors

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…

Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site

The announcement comes weeks after President Donald Trump inked deals with Eli Lilly and Novo Nordisk to make their GLP-1…

Eli Lillys price cut, Thanksgiving box office, trouble for gravestone makers and more in Morning Squawk

Here are five key things investors need to know to start the trading day.…

Eli Lilly cuts price of Zepbound in heightened weight-loss drug competition

Eli Lilly and Co (NYSE:LLY) said on Monday it is lowering the cash prices of its weight-loss drug Zepbound, marking…

Market Data

Out of nowhere, on a holiday week no less, it seemed the stock market got a bid. The result was…

What comes next for Eli Lilly stock after $1T valuation? By Investing.com

What comes next for Eli Lilly stock after $1T valuation?…

Micron, Eli Lilly among market cap stock movers on Friday By Investing.com

Micron, Eli Lilly among market cap stock movers on Friday…

Amphastar (AMPH) Q3 2025 Earnings Call Transcript

Image source: The Motley Fool.DateSaturday, Nov. 8, 2025 at 12:16 p.m. ETCall participantsChief Commercial Officer — Dan DischnerChief Financial Officer…

Lillys Moment: AI-Powered Pipeline Positions Shares to Surge in 2026

Eli Lillys stock is surging amid a flurry of AI deals. Our proprietary Zacks Rank system confirms the trend.…

Top analyst drops jaw-dropping price target on Eli Lilly stock

Bernstein just threw fresh fuel on Eli Lillys (LLY) never-ending rally, as the firm lifted its price target on the…

Novo Nordisk stumbles against Eli Lilly in GLP-1 drug battle. Which stock is the best buy from here?

Eli Lillys stock is soaring while Novo Nordisk is sinking. Why it makes sense to stick with the market winner,…

This Healthcare Company Just Touched $1 Trillion in Market Cap. Should You Invest $1,000?

The rapidly expanding market for GLP-1 drugs has added massively to Eli Lillys market cap.…

Here are Mondays biggest analyst calls: Nvidia, Apple, Tesla, Ferrari, Carvana, Eli Lilly, Amazon, Walmart & more

Here are Mondays biggest calls on Wall Street.…

Eli Lilly: Neuer 1 Bio. USD-Gigant! Abnehmmedikamente treiben das Pharma-Schwergewicht zu neuen Höhen!

Die Angst geht um an den US-Börsen. Der Fear & Greed Index rutschte zuletzt unter 10 und erreichte ein Level…

Billionaire Stanley Druckenmiller Dropped Nvidia, Palantir, and Eli Lilly Over the Past Year and Just Bought the 2 Cheapest Magnificent Seven Stocks.

These Magnificent Seven players are well-positioned to benefit in the AI boom.…

Eli Lilly: The Weight-Loss Leader With More Upside If Execution Holds

…

When Investors Panic, I Buy Eli Lilly

…

AKTIE IM FOKUS 2: Eli Lilly knackt Marke von 1 Billion Dollar Börsenwert

(neu: Aktienkurs aktualisiert) NEW YORK (dpa-AFX) - Als erstes Pharmaunternehmen hat Eli Lilly…

AKTIE IM FOKUS: Eli Lilly knackt nach Rally Marke von 1 Billion Dollar Marktwert

NEW YORK (dpa-AFX) - Als erstes Pharmaunternehmen hat Eli Lilly am Freitag mit dem Börsenwert…

Eli Lilly hits $1 trillion market value, a first for a health-care company

The pharmaceutical giant Eli Lillys stock has been riding the skyrocketing demand for its weight loss injection Zepbound and diabetes…

Lilly becomes first drugmaker to join trillion-dollar club on weight-loss demand boom

Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club…

Heres Why Eli Lilly (LLY) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why…

Novo, Lilly collaborate with Waltz Health to sell weight-loss drugs directly to employers

Digital health company Waltz Health said on Friday it has launched a program to offer popular weight-loss drugs from Novo…

Eli Lilly first healthcare company to hit $1T market capitalization

Eli Lilly and Co (NYSE:LLY) briefly reached a market capitalization of $1 trillion during trading on Friday, making it the…

Analysts get more bullish on this non-tech stock

The market has been swinging recently, with the S&P 500 index down 1.5% and the Nasdaq Composite down more than…

Heres Why Eli Lilly (LLY) is a Strong Growth Stock

Whether youre a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top…

Head and Neck Squamous Cell Carcinoma Market Research Report 2025-2035: Sanofi, Sun Pharma, and Eli Lilly Lead Through the Development of New Drugs, Clinical Trials, Combination Treatment Strategies

The global head and neck squamous cell carcinoma market is set for steady growth, driven by advancements in treatment options,…

Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.

These stocks both have advanced in the double-digits in recent months.…

Why Big Pharma Wont Quit the Diet. Who Will Win the Next Weight Loss Battle?

The next generation of weight loss drugs will hit the market in 2026. Eli Lilly and Novo Nordisk are racing…

Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month

The announcements come days after President Donald Trump struck deals with Novo Nordisk and Eli Lilly to make their GLP-1s…

Eli Lilly and Novo Nordisk May Soon Sell Weight Loss Drugs on the Planned TrumpRx. Could This Further Boost the Healthcare Giants Stocks?

Investors will be watching what Trump makes happen.…

Prediction: This Will Be Wall Streets Next Trillion-Dollar Stock

Drugs for weight loss and diabetes are taking Eli Lilly to new heights.…

Notable analyst calls this week: Eli Lilly, Nvidia and Skyworks among top picks

…

Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs

Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“Mangoceuticals” or the “Company”) is issuing…

1 Incredible Reason to Buy LLYs Stock in November

Eli Lilly struck a deal with President Donald Trump last week that could send the stock much higher.…

Eli Lilly stock tops $1,000 for the first time. Cramer says the next milestone is within reach

"People are beginning to realize maybe this thing is worth far more," CNBCs Jim Cramer says.…

Eli Lilly ist der bei GLP-1-Marktführer mit Erlösen von 125 Mrd. USD bis 2030. Warum die Aktie noch 50%iges Potenzial hat!

Der Kampf um die Krone bei GLP-1-Produkten tobt. Mit Eli Lilly zeichnet sich ein Gewinner ab. Eli Lilly untermauert seine…

dpa-AFX ProFeed